SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 14.50
0.00 (0.00%)
Oct 10, 2025, 4:39 PM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 37.52 million as of October 10, 2025. Its market cap has increased by 52.61% in one year.
Market Cap
37.52M
Enterprise Value
37.31M
Revenue
2.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.50
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 37.52M, an increase of 138.56%. That is a compound annual growth rate of 10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 37.52M | -11.21% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | 36.63M | 97.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.21B |
| GSK plc | 65.38B |
| Haleon | 30.16B |
| Smith & Nephew | 11.23B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 4.02B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.68B |